Gene · 10561
Papers3,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maternal hyperglycemia induces alterations in hepatic amino acid, glucose and lipid metabolism of neonatal offspring: Multi-omics insights from a diabetic pig model. | Mol Metab | 2023 | 37414142 | PubTator, text mining | PubMed |
| Towards unravelling biological mechanisms behind radiation-induced oral mucositis via mass spectrometry-based proteomics. | Front Oncol | 2023 | 37384298 | PubTator, text mining | PubMed |
| Editorial: Diagnosis and treatment of sarcoidosis. | Front Med (Lausanne) | 2023 | 37384042 | PubTator, text mining | PubMed |
| Correlation between immune-related genes and depression-like features in an animal model and in humans. | Brain Behav Immun | 2023 | 37379963 | PubTator, text mining | PubMed |
| Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. | Int J Mol Sci | 2023 | 37373115 | PubTator, text mining | PubMed |
| Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition. | J Clin Immunol | 2023 | 37358695 | PubTator, text mining | PubMed |
| Spinal cord injury: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37357239 | PubTator, text mining | PubMed |
| Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review). | Int J Mol Med | 2023 | 37350412 | PubTator, text mining | PubMed |
| Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs. | Sci Rep | 2023 | 37344505 | PubTator, text mining | PubMed |
| Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses. | Sci Adv | 2023 | 37343108 | PubTator, text mining | PubMed |
| IFIH1 and DDX58 gene variants in pediatric rheumatic diseases. | World J Clin Pediatr | 2023 | 37342449 | PubTator, text mining | PubMed |
| Pregnancy-associated systemic gene expression compared to a pre-pregnancy baseline, among healthy women with term pregnancies. | Front Immunol | 2023 | 37342349 | PubTator, text mining | PubMed |
| Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma. | Cancer Med | 2023 | 37341071 | PubTator, text mining | PubMed |
| Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma. | Mol Oncol | 2023 | 37341059 | PubTator, text mining | PubMed |
| IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system. | Proc Natl Acad Sci U S A | 2023 | 37339207 | PubTator, text mining | PubMed |
| Revealing common differential mRNAs, signaling pathways, and immune cells in blood, glomeruli, and tubulointerstitium of lupus nephritis patients based on transcriptomic data. | Ren Fail | 2023 | 37334926 | PubTator, text mining | PubMed |
| Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases. | Mediators Inflamm | 2023 | 37332618 | PubTator, text mining | PubMed |
| Identification of molecular mechanisms causing skin lesions of cutaneous leishmaniasis using weighted gene coexpression network analysis (WGCNA). | Sci Rep | 2023 | 37330553 | PubTator, text mining | PubMed |
| Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis. | Front Immunol | 2023 | 37325639 | PubTator, text mining | PubMed |
| Irradiation-induced IFN-type-I pathway activation in prostate cancer cell lines. | Cytokine | 2023 | 37301190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10561/papers?page=13